Mesenchymal Stem Cells (MSC)

Research OnlyModerate Evidence
Written by dr-sarah-chen|Reviewed by Healthier Rx Editorial Board|Updated 2026-03-25|3 min read
Quick Facts
TypeRegenerative Medicine
FDA StatusResearch Only
Evidence LevelModerate Evidence
Typical DoseVaries by indication and source
FrequencySingle or series of treatments
Cycle Length1-3 sessions over 3-6 months
Key GoalsAnti-Aging, Injury Recovery, Joint Health

How It Works

Mesenchymal stem cells are multipotent progenitor cells that can differentiate into multiple tissue types. Their therapeutic potential comes primarily from their paracrine signaling — they secrete growth factors, cytokines, and extracellular vesicles that modulate inflammation, promote tissue repair, and recruit other healing cells to damaged areas.

MSCs can be derived from bone marrow, adipose tissue, umbilical cord tissue (Wharton's jelly), and other sources. Each source has different characteristics and potential advantages.

Benefits

  • Anti-inflammatory and immunomodulatory effects
  • Promotion of tissue regeneration and repair
  • Potential joint and cartilage restoration
  • Neuroprotective properties in preclinical studies
  • Anti-aging effects through systemic signaling

Side Effects

  • Injection site reactions — pain, swelling
  • Mild fever — within 24-48 hours of treatment
  • Headache — occasionally reported
  • Risk of infection — if clinic protocols are inadequate
  • Theoretical risk of ectopic tissue formation — not observed in clinical studies

Frequently Asked Questions

References

  1. Mesenchymal stem cells in regenerative medicineStem Cell Research & Therapy (2021). PMID: 33397467

    Comprehensive review of MSC applications in regenerative medicine across multiple organ systems.

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new treatment or protocol. Read our full medical disclaimer.